Recurrent Metaplastic Breast Cancer with Subtype Converted from Triple-Negative to HER2-Positive: A Case Report and Literature Review.

Wu, Jing; Jin, Yudi; Liu, Mei; Zhu, Ningsheng; Jing, Zhouhong; Zeng, Xiaohua

Wu, Jing; Jin, Yudi; Liu, Mei; Zhu, Ningsheng; Jing, Zhouhong; Zeng, Xiaohua.

Afiliação

Wu J; Department of Breast Center, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Jin Y; Department of Pathology, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Liu M; Department of Breast Center, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Zhu N; Department of Breast Center, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Jing Z; Department of Breast Center, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.
Zeng X; Department of Breast Center, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China.

Breast Cancer (Dove Med Press) ; 15: 39-45, 2023.

Article em En | MEDLINE | ID: mdl-36698553

Palavras-chave

HER2-positive; metaplastic breast cancer; recurrence; targeted therapy; triple-negative

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Breast Cancer (Dove Med Press) Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google